← back to search

Sirpa Hartikainen

University of Eastern Finland · FI
Area of research
Psychiatry and Mental health · Geriatrics and Gerontology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Pharmaceutical Practices and Patient Outcomes, Schizophrenia research and treatment, and Alzheimer's disease research and treatments.
h-index
51
citations
11,414
works
314
NIH funding
primary concept
email

Recent publications

Older adult risk classification for anticholinergics (ORCA): a Delphi panel-validated scale
Age and Ageing 2025cited by 1position: middledoi
Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities
Journal of the American Medical Directors Association 2024cited by 4position: middledoi
STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs
Age and Ageing 2020cited by 249position: middledoi
Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education
Journal of the American Medical Directors Association 2020cited by 78position: middledoi
Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)
CNS Drugs 2020cited by 27position: middledoi
Metformin and Risk of Alzheimer’s Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study
The Journal of Clinical Endocrinology & Metabolism 2019cited by 97position: lastdoi
EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
Drugs & Aging 2019cited by 61position: middledoi
EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
European Geriatric Medicine 2019cited by 37position: middledoi
Use of Antiepileptic Drugs and Dementia Risk—an Analysis of Finnish Health Register and German Health Insurance Data
Journal of the American Geriatrics Society 2018cited by 58position: middledoi
Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease
European Neuropsychopharmacology 2018cited by 46position: lastdoi
No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer’s Disease
The American Journal of Gastroenterology 2017cited by 94position: lastdoi
Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease
Canadian Medical Association Journal 2017cited by 71position: lastdoi
Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: A nationwide nested case-control study
European Psychiatry 2017cited by 62position: middledoi
Risk of Alzheimer’s disease among users of postmenopausal hormone therapy: A nationwide case-control study
Maturitas 2017cited by 58position: middledoi
Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study
BMJ Open 2016cited by 97position: lastdoi
Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons
Clinical Epidemiology 2016cited by 71position: lastdoi
From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
BMC Medical Informatics and Decision Making 2015cited by 200position: middledoi
Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study
PLoS ONE 2014cited by 104position: middledoi
High prevalence of psychotropic drug use among persons with and without Alzheimer׳s disease in Finnish nationwide cohort
European Neuropsychopharmacology 2014cited by 72position: lastdoi
Antidementia drug use among community-dwelling individuals with Alzheimer’s disease in Finland
International Clinical Psychopharmacology 2014cited by 54position: lastdoi
Analgesic Use and Frailty among Community-Dwelling Older People
Drugs & Aging 2013cited by 56position: lastdoi
Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer’s disease research – the Medication use among persons with Alzheimer’s disease (MEDALZ-2005) study
Clinical Epidemiology 2013cited by 49position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Anna‐Maija Tolppanen · University of Eastern Finland14 papers (2013–2019)Heidi Taipale · University of Eastern Finland14 papers (2013–2019)Jari Tiihonen · University of Eastern Finland13 papers (2013–2019)Antti Tanskanen · University of Eastern Finland12 papers (2013–2019)Marjaana Koponen · University of Eastern Finland11 papers (2013–2019)J. Simon Bell · Monash University4 papers (2013–2020)Piia Lavikainen · University of Eastern Finland3 papers (2013–2017) · 2 papers (2017–2017)Janet K. Sluggett · University of South Australia2 papers (2019–2020)Hilkka Soininen · Charles University1 papers (2017–2017)Davide Liborio Vetrano · Stockholm University1 papers (2020–2020)Lucas Morin · Inserm1 papers (2020–2020)Siska Desplenter · KU Leuven1 papers (2013–2013) · 1 papers (2025–2025)Samanta Lalic · Monash University1 papers (2020–2020) · 1 papers (2025–2025)Tomas Welsh · Allen Institute for Brain Science1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2017–2017) · 1 papers (2018–2018)